Role of c-Abl tyrosine kinase in smooth muscle cell migration

American Journal of Physiology - Cell Physiology

Volumn 306, Issue 8, 2014, Pages

  Cleary, Rachel A ^a   Wang, Ruping ^a   Waqar, Omar ^a   Singer, Harold A ^a   Tang, Dale D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Actin cytoskeleton; Adapter protein; Cell migration; Smooth muscle; Tyrosine kinase

Indexed keywords

ABELSON KINASE; BETA1 INTEGRIN; CORTACTIN; PROFILIN;

ACTIN POLYMERIZATION; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL MOTION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SMOOTH MUSCLE FIBER;

ACTIN CYTOSKELETON; ADAPTER PROTEIN; CELL MIGRATION; SMOOTH MUSCLE; TYROSINE KINASE;

ANIMALS; ANTIGENS, CD29; BLOTTING, FAR-WESTERN; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CORTACTIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROFILINS; PROTO-ONCOGENE PROTEINS C-ABL; RNA INTERFERENCE; TRANSDUCTION, GENETIC;

EID: 84900544704     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00327.2013     Document Type: Article

References (40)

1. Ammer AG, Weed SA. Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil Cytoskeleton 65: 687-707, 2008.
2. Anfinogenova Y, Wang R, Li QF, Spinelli AM, Tang DD. Abl silencing inhibits CAS-Mediated process and constriction in resistance arteries. Circ Res 101: 420-428, 2007.
3. Balamatsias D, Kong AM, Waters JE, Sriratana A, Gurung R, Bailey CG, Rasko JE, Tiganis T, Macaulay SL, Mitchell CA. Identification of P-Rex1 as a novel Rac1-guanine nucleotide exchange factor (GEF) that promotes actin remodeling and GLUT4 protein trafficking in adipocytes. J Biol Chem 286: 43229-43240, 2011.
4. Baruzzi A, Iacobucci I, Soverini S, Lowell CA, Martinelli G, Berton G. c-Abl and Src-family kinases cross-talk in regulation of myeloid cell migration. FEBS Lett 584: 15-21, 2010.
5. Boudreau NJ, Jones PL. Extracellular matrix and integrin signalling: the shape of things to come. Biochem J 339: 481-488, 1999.
6. Boukhelifa M, Moza M, Johansson T, Rachlin A, Parast M, Huttelmaier S, Roy P, Jockusch BM, Carpen O, Karlsson R, Otey CA. The proline-rich protein palladin is a binding partner for profilin. FEBS J 273: 26-33, 2006.
7. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 57: 559-577, 2005.
8. Chen S, Wang R, Li QF, Tang DD. Abl knockout differentially affects p130 Crk-associated substrate, vinculin, and paxillin in blood vessels of mice. Am J Physiol Heart Circ Physiol 297: H533-H539, 2009.
9. Cosen-Binker LI, Kapus A. Cortactin: the gray eminence of the cytoskeleton. Physiology (Bethesda) 21: 352-361, 2006.
10. del Pozo MA, Price LS, Alderson NB, Ren XD, Schwartz MA. Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J 19: 2008-2014, 2000.
11. Ding ZJ, Lambrechts A, Parepally M, Roy P. Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis. J Cell Sci 119: 4127-4137, 2006.
12. Fan Y, Arif A, Gong YQ, Jia J, Eswarappa SM, Willard B, Horowitz A, Graham LM, Penn MS, Fox PL. Stimulus-dependent phosphorylation of profilin-1 in angiogenesis. Nat Cell Biol 14: 1046-1056, 2012.
13. Gerthoffer WT. Mechanisms of vascular smooth muscle cell migration. Circ Res 100: 607-621, 2007.
14. Gerthoffer WT. Migration of airway smooth muscle cells. Proc Am Thorac Soc 5: 97-105, 2008.
15. Goncharova EA, Goncharov DA, Zhao H, Penn RB, Krymskaya VP, Panettieri RA Jr. Beta2-adrenergic receptor agonists modulate human airway smooth muscle cell migration via vasodilator-stimulated phosphoprotein. Am J Respir Cell Mol Biol 46: 48-54, 2012.
16. Hu H, Bliss JM, Wang Y, Colicelli J. RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration. Curr Biol 15: 815-823, 2005.
17. Jallal H, Valentino ML, Chen G, Boschelli F, Ali S, Rabbani SA. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo. Cancer Res 67: 1580-1588, 2007.
18. Jia L, Tang DD. Abl activation regulates the dissociation of CAS from cytoskeletal vimentin by modulating CAS phosphorylation in smooth muscle. Am J Physiol Cell Physiol 299: C630-C637, 2010.
19. Jia L, Wang R, Tang DD. Abl regulates smooth muscle cell proliferation by modulating actin dynamics and ERK1/2 activation. Am J Physiol Cell Physiol 302: C1026-C1034, 2012.
20. Kain KH, Klemke RL. Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes. J Biol Chem 276: 16185-16192, 2001.
21. Khusial RP, Vadla B, Krishnan H, Ramlall TF, Shen Y, Ichikawa H, Geng JG, Goldberg GS. Src activates Abl to augment Robo1 expression in order to promote tumor cell migration. Oncotarget 1: 198-209, 2010.
22. Lapetina S, Mader CC, Machida K, Mayer BJ, Koleske AJ. Arg interacts with cortactin to promote adhesion-dependent cell edge protrusion. J Cell Biol 185: 503-519, 2009.
23. Li QF, Spinelli AM, Tang DD. Cdc42GAP, reactive oxygen species, and the vimentin network. Am J Physiol Cell Physiol 297: C299-C309, 2009.
24. Li QF, Spinelli AM, Wang R, Anfinogenova Y, Singer HA, Tang DD. Critical role of vimentin phosphorylation at Ser-56 by p21-activated kinase in vimentin cytoskeleton signaling. J Biol Chem 281: 34716-34724, 2006.
25. Parkash J, Cimino I, Ferraris N, Casoni F, Wray S, Cappy H, Prevot V, Giacobini P. Suppression of beta1-integrin in gonadotropin-releasing hormone cells disrupts migration and axonal extension resulting in severe reproductive alterations. J Neurosci 32: 16992-17002, 2012.
26. Petrie RJ, Doyle AD, Yamada KM. Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 10: 538-549, 2009.
27. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112: 453-465, 2003.
28. Qiu Z, Cang Y, Goff SP. c-Abl tyrosine kinase regulates cardiac growth and development. Proc Natl Acad Sci USA 107: 1136-1141, 2010.
29. Tang DD. p130 Crk-associated substrate (CAS) in vascular smooth muscle. J Cardiovasc Pharmacol Ther 14: 89-98, 2009.
30. Tang DD, Anfinogenova Y. Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle. J Cardiovasc Pharmacol Ther 13: 130-140, 2008.
31. Tang DD, Bai Y, Gunst SJ. Silencing of p21-activated kinase attenuates vimentin phosphorylation on Ser-56 and reorientation of the vimentin network during stimulation of smooth muscle cells by 5-hydroxytryptamine. Biochem J 388: 773-783, 2005.
32. Tang DD, Tan J. Downregulation of profilin with antisense oligodeoxynucleotides inhibits force development during stimulation of smooth muscle. Am J Physiol Heart Circ Physiol 285: H1528-H1536, 2003.
33. Tang DD, Tan J. Role of Crk-associated substrate in the regulation of vascular smooth muscle contraction. Hypertension 42: 858-863, 2003.
34. Wang JY. Controlling Abl: auto-inhibition and co-inhibition? Nat Cell Biol 6: 3-7, 2004.
35. Wang R, Li QF, Anfinogenova Y, Tang DD. Dissociation of Crkassociated substrate from the vimentin network is regulated by p21-activated kinase on ACh activation of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 292: L240-L248, 2007.
36. Wang R, Mercaitis OP, Jia L, Panettieri RA, Tang DD. Raf-1, actin dynamics and Abl in human airway smooth muscle cells. Am J Respir Cell Mol Biol 48: 172-178, 2013.
37. Wang T, Cleary RA, Wang R, Tang DD. Role of the adapter protein Abi1 in actin-associated signaling and smooth muscle contraction. J Biol Chem 288: 20713-20722, 2013.
38. Witke W. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol 14: 461-469, 2004.
39. Woodring PJ, Meisenhelder J, Johnson SA, Zhou GL, Field J, Shah K, Bladt F, Pawson T, Niki M, Pandolfi PP, Wang JY, Hunter T. c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. J Cell Biol 165: 493-503, 2004.
40. Zhang J, Adrian FJ, Jahnke W, Cowan-Jacob SW, Li AG, Iacob RE, Sim T, Powers J, Dierks C, Sun F, Guo GR, Ding Q, Okram B, Choi Y, Wojciechowski A, Deng X, Liu G, Fendrich G, Strauss A, Vajpai N, Grzesiek S, Tuntland T, Liu Y, Bursulaya B, Azam M, Manley PW, Engen JR, Daley GQ, Warmuth M, Gray NS. Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature 463: 501-506, 2010.